These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11870878)

  • 21. Polycystin-1 interacts with E-cadherin and the catenins--clues to the pathogenesis of cyst formation in ADPKD?
    van Adelsberg J
    Nephrol Dial Transplant; 2000 Jan; 15(1):1-2. PubMed ID: 10607757
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
    Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
    Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?
    Weimbs T
    Cell Cycle; 2006 Nov; 5(21):2425-9. PubMed ID: 17102641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of cadherin/catenin complexes in transformed thyroid epithelial cells: modulation by beta 1 integrin subunit.
    Celetti A; Garbi C; Consales C; Cerrato A; Greco D; Mele E; Nitsch L; Grieco M
    Eur J Cell Biol; 2000 Sep; 79(9):583-93. PubMed ID: 11043399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue.
    Ong AC; Harris PC; Davies DR; Pritchard L; Rossetti S; Biddolph S; Vaux DJ; Migone N; Ward CJ
    Kidney Int; 1999 Oct; 56(4):1324-33. PubMed ID: 10504485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The loss of tuberin promotes cell invasion through the ß-catenin pathway.
    Barnes EA; Kenerson HL; Mak BC; Yeung RS
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):617-27. PubMed ID: 20042714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.
    Oyama T; Kanai Y; Ochiai A; Akimoto S; Oda T; Yanagihara K; Nagafuchi A; Tsukita S; Shibamoto S; Ito F
    Cancer Res; 1994 Dec; 54(23):6282-7. PubMed ID: 7954478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia.
    Bush KT; Tsukamoto T; Nigam SK
    Am J Physiol Renal Physiol; 2000 May; 278(5):F847-52. PubMed ID: 10807598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
    Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
    J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
    El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
    J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
    Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
    Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles.
    Plank TL; Yeung RS; Henske EP
    Cancer Res; 1998 Nov; 58(21):4766-70. PubMed ID: 9809973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annexin A5 interacts with polycystin-1 and interferes with the polycystin-1 stimulated recruitment of E-cadherin into adherens junctions.
    Markoff A; Bogdanova N; Knop M; Rüffer C; Kenis H; Lux P; Reutelingsperger C; Todorov V; Dworniczak B; Horst J; Gerke V
    J Mol Biol; 2007 Jun; 369(4):954-66. PubMed ID: 17451746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tuberous sclerosis complex genes in tumor development.
    Mak BC; Yeung RS
    Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
    Soucek T; Pusch O; Wienecke R; DeClue JE; Hengstschläger M
    J Biol Chem; 1997 Nov; 272(46):29301-8. PubMed ID: 9361010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells.
    Näthke IS; Hinck L; Swedlow JR; Papkoff J; Nelson WJ
    J Cell Biol; 1994 Jun; 125(6):1341-52. PubMed ID: 8207062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours.
    Alami J; Williams BR; Yeger H
    Mol Pathol; 2003 Aug; 56(4):218-25. PubMed ID: 12890743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.
    Nguyen-Vu PA; Fackler I; Rust A; DeClue JE; Sander CA; Volkenandt M; Flaig M; Yeung RS; Wienecke R
    J Cutan Pathol; 2001 Oct; 28(9):470-5. PubMed ID: 11553313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.